Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.
With puromycin aminonucleoside-induced nephrotic syndrome (NS) in rats, twofold elevated levels of lipoproteins were observed. These levels were not related to proteinuria or to plasma albumin levels. Ultrastructural lesions induced in the kidneys by puromycin aminonucleoside were consistent with NS, while there was little or no hepatic involvement. Apolipoprotein B (apo B) kinetic measurements using homologous 125I-labeled low density lipoproteins (LDL) demonstrated a higher synthetic rate in nephrotic rats relative to controls (6.18 +/- 1.86 micrograms x g-1 x d-1 v 3.94 +/- 0.66 micrograms x g-1 x d-1 respectively, P less than .005), while the fractional catabolic rate was only marginally reduced (1.64 +/- 0.28 pools x day-1 in NS v 1.83 +/- 0.37 pools x day-1 in controls, P less than 0.4). These results indicate that in rats with experimentally induced NS, the expanded apo B-LDL pool results from increased synthesis of this apoprotein while no significant role can be ascribed to alterations in its catabolism. These data are consistent with our preliminary findings in NS in humans.
Joven
J
J
Unitat de Recerca de Lipids, Facultad de Medicina de Reus, Hospital de Sant Joan de Reus, Spain.
Masana
L
L
Villabona
C
C
Vilella
E
E
Bargalló
T
T
Trias
M
M
Figueras
M
M
Turner
P R
PR
D000818:Animals; D002784:Cholesterol / Q000097:blood; D007668:Kidney / Q000473:pathology; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D008099:Liver / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000097:blood* / Q000139:chemically induced / Q000473:pathology; D011692:Puromycin Aminonucleoside; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000032:analysis
D008055:Lipids; D008077:Lipoproteins, LDL; D012709:Serum Albumin; D011692:Puromycin Aminonucleoside; D002784:Cholesterol